247 results on '"Yeh, Jen Jen"'
Search Results
2. Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
3. Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model
4. Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
5. Future of Dendritic Cell–Based Approaches in Pancreatic Cancer.
6. Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines.
7. Pathology and Molecular Characteristics of Pancreatic Cancer
8. The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
9. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
10. Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer.
11. First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma.
12. Efficient computation of high-dimensional penalized generalized linear mixed models by latent factor modeling of the random effects.
13. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth
14. Use of iontophoresis for the treatment of cancer
15. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
16. A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.
17. Purity Independent Subtyping of Tumors Pancreatic Cancer Classifier: Analytic Validation of a 16-RNA Expression Signature Distinguishing Basal and Classical Subtypes
18. Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer
19. Altered exocrine function can drive adipose wasting in early pancreatic cancer
20. Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma
21. De novo compartment deconvolution and weight estimation of tumor samples using DECODER
22. Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis.
23. Sub-Cluster Identification through Semi-Supervised Optimization of Rare-Cell Silhouettes (SCISSORS) in single-cell RNA-sequencing.
24. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs
25. Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma
26. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
27. PTEN : Regulator of Phosphoinositide 3-Kinase Signal Transduction
28. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
29. Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule
30. Age and Breslow Depth Are Associated with a Positive Sentinel Lymph Node in Patients with Cutaneous Melanocytic Tumors of Uncertain Malignant Potential
31. Metastatic Melanoma Cells in the Sentinel Node Cannot Be Ignored
32. Promise of bile circulating tumor DNA in biliary tract cancers.
33. Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging
34. HIF2[alpha] cooperates with RAS to promote lung tumorigenesis in mice
35. Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling.
36. High dimensional precision medicine from patient-derived xenografts
37. Limitations of Ampullectomy in the Treatment of Nonfamilial Ampullary Neoplasms
38. Effectiveness of Palliative Procedures for Intra-Abdominal Sarcomas
39. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model
40. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours
41. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
42. Utilization of total thyroidectomy for papillary thyroid cancer in the United States
43. The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies.
44. High-Dimensional Precision Medicine From Patient-Derived Xenografts.
45. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy
46. Semaphorin 4D Blockade Enhances T-Cell Penetration and Potentiates Response to Immune Checkpoint Blockade in a Murine Model of Pancreatic Cancer
47. Gene Targeting in Disease Networks.
48. Modeling Between-Study Heterogeneity for Improved Reproducibility in Gene Signature Selection and Clinical Prediction
49. Modeling Between-Study Heterogeneity for Improved Replicability in Gene Signature Selection and Clinical Prediction.
50. A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.